Skip to main content
Clinical Trials/NCT03124277
NCT03124277
Completed
Not Applicable

A Whey Protein-based Nutritional Supplement Enriched in Vitamin D, Leucine and Calcium for Patients With Parkinsonism Undergoing Rehabilitation Treatment: a Randomized Trial

Emanuele Cereda1 site in 1 country150 target enrollmentApril 26, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Disability Physical
Sponsor
Emanuele Cereda
Enrollment
150
Locations
1
Primary Endpoint
Functional status - distance walked during the six minutes walking test
Status
Completed
Last Updated
last year

Overview

Brief Summary

This randomized, trial will tested the hypothesis that nutritional supplementation with whey protein, essential amino acids - mainly leucine - vitamin D and calcium would increase the efficacy of physical rehabilitation in old adults suffering from Parkinson's disease o parkinsonism

Registry
clinicaltrials.gov
Start Date
April 26, 2017
End Date
January 17, 2018
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Emanuele Cereda
Responsible Party
Sponsor Investigator
Principal Investigator

Emanuele Cereda

Co-Project Investigator

Fondazione IRCCS Policlinico San Matteo di Pavia

Eligibility Criteria

Inclusion Criteria

  • Parkinson's disease o parkinsonism
  • admission for physical rehabilitation
  • Informed consent

Exclusion Criteria

  • Any malignant disease during the last five years
  • Known kidney failure (previous glomerular filtration rate \<30 ml/min);
  • Known liver failure (Child B or C)
  • Psychiatric disease
  • Endocrine disorders associated with disorders of calcium metabolism (excluding osteoporosis)
  • Indications related to the study product:
  • More than 10 μg (400 IU) of daily Vitamin D intake from medical sources More than 500 mg of daily calcium intake from medical sources. Adherence to a high energy or high protein diet up or use of protein containing or amino acid containing nutritional supplements up to three months before starting the study.
  • Known allergy to milk, milk products or other components of the proposed interventions
  • Indication to or ongoing artificial nutrition support
  • Inclusion in other nutrition intervention trials

Outcomes

Primary Outcomes

Functional status - distance walked during the six minutes walking test

Time Frame: 30 days

Change in the distance walked during the six minutes walking test

Secondary Outcomes

  • Adverse events(30 days)
  • Functional status - timed up and go test(30 days)
  • Self-perceived functional status(30 days)
  • Functional status - Berg balance scale(30 days)
  • Functional status - gait speed(30 days)
  • Muscle mass(30 days)
  • Treatment continuation(30 days)
  • Functional status - handgrip strength(30 days)
  • Body weight(30 days)

Study Sites (1)

Loading locations...

Similar Trials